Kaja Scheibe
Overview
Explore the profile of Kaja Scheibe including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
29
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Serwin K, Scheibe K, Urbanska A, Aksak-Was B, Karasinska-Cieslak M, Zabek P, et al.
J Med Virol
. 2024 Feb;
96(2):e29482.
PMID: 38381668
The human immunodeficiency virus type 1 (HIV-1) A6 sub-subtype is highly prevalent in Eastern Europe. Over the past decade, the dissemination of the A6 lineage has been expanding in Poland....
2.
Parczewski M, Jablonowska E, Wojcik-Cichy K, Zhyvytsia D, Witak-Jedra M, Leszczyszyn-Pynka M, et al.
Clin Infect Dis
. 2023 Mar;
76(10):1708-1715.
PMID: 36888680
Background: The Russian invasion of Ukraine forced migration for safety, protection, and assistance. Poland is the primary sheltering country for Ukrainian refugees, providing support including medical care, which resulted in...
3.
Serwin K, Chaillon A, Scheibe K, Urbanska A, Aksak-Was B, Zabek P, et al.
Clin Infect Dis
. 2023 Mar;
76(10):1716-1724.
PMID: 36857116
Background: The human immunodeficiency virus (HIV) type 1 A6 variant is dominating in high-prevalence Eastern European countries, with increasing prevalence over the remaining regions of Europe. The recent war in...
4.
Serwin K, Scheibe K, Horecki M, Aksak-Was B, Jasik M, Parczewski M
J Med Virol
. 2022 Sep;
95(1):e28154.
PMID: 36109345
Infection with the human immunodeficiency virus type 1 (HIV-1) subtype B is most commonly acquired in Poland through men who have sex with men (MSM) comparable to the HIV epidemic...
5.
Scheibe K, Urbanska A, Serwin K, Parczewski M
Infect Genet Evol
. 2022 Sep;
104:105358.
PMID: 36057423
Objectives: The long-acting injectable (LAI) cabotegravir (CAB) and rilpivirine (RPV) treatment offers important advantages over oral ART (antiretroviral therapy), however baseline factors possibly contributing to the CAB/RPV treatment failure were...
6.
Aksak-Was B, Chober D, Serwin K, Scheibe K, Niscigorska-Olsen J, Niedzwiedz A, et al.
J Inflamm Res
. 2022 Sep;
15:4907-4920.
PMID: 36046662
Introduction: Remdesivir is the first agent with proven clinical efficacy against coronavirus disease 2019 (COVID-19); however, its benefit is associated with early use, and its efficacy has been poorly studied...
7.
Scheibe K, Urbanska A, Jakubowski P, Hlebowicz M, Bociaga-Jasik M, Raczynska A, et al.
Antivir Ther
. 2022 Apr;
26(3-5):69-78.
PMID: 35485331
Introduction: Doravirine (DOR) is a novel non-nucleoside reverse transcriptase inhibitor (NNRTI) that retains activity against common NNRTI resistance mutations. In this study, we aimed to investigate the prevalence of DOR...
8.
Aksak-Was B, Urbanska A, Scheibe K, Serwin K, Leszczyszyn-Pynka M, Rafalska-Kosior M, et al.
J Clin Med
. 2022 Apr;
11(7).
PMID: 35407496
Introduction: Immune restoration is a key clinical aspect that is pursued in the care of human immunodeficiency virus (HIV)-infected patients. Despite effective antiretroviral treatment and undetectable viremia, immune recovery is...
9.
Serwin K, Urbanska A, Scheibe K, Witak-Jedra M, Jankowska M, Hlebowicz M, et al.
Sci Rep
. 2021 Aug;
11(1):16609.
PMID: 34400726
The occurrence of HIV-1 subtypes differs worldwide and within Europe, with non-B variants mainly found across different exposure groups. In this study, we investigated the distribution and temporal trends in...
10.
Parczewski M, Sulkowska E, Urbanska A, Scheibe K, Serwin K, Grabarczyk P
Sci Rep
. 2021 Jun;
11(1):12734.
PMID: 34140600
Surveillance on the HIV molecular variability, risk of drug resistance transmission and evolution of novel viral variants among blood donors remains an understudied aspect of hemovigilance. This nationwide study analyses...